Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPLE: Lapatinib in presurgical breast cancer
NCT00299286Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by The Institute of Cancer Research. Started Jun 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00299286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299286.